Licensing, Generic Competition Needed To Drive Down HIV Drug Prices, Speakers Say
The accessibility and affordability of drugs in developing countries depend on robust generic competition and would benefit from greater transparency in the terms and conditions of licensing agreements, the acting head of the Medicines Patent Pool said on a panel at the World Intellectual Property Organization that included a speaker from the Indian generics industry and a representative of Gilead Sciences.
